Aleris Eye

Aleris is one of Scandinavia’s largest private providers of specialist healthcare, operating hospitals and clinics in Sweden, Norway, and Denmark. The company offers high-quality medical services across multiple specialties including ophthalmology/eye care. It does not develop its own drugs or biologics but participates in clinical research as an investigator site or sponsor for trials involving approved therapies such as ranibizumab for eye disease. The company has demonstrated strong growth through acquisitions and digital innovation—such as launching digital video consultations and the Doktor24 triage platform—and continues to expand access to specialist care throughout the region. There is no evidence that "Aleris Eye" exists as an independent legal entity or brand distinct from the broader ophthalmic service line within Aleris.